ZVIA
Zevia PBC2.5800
+0.0800+3.2%
Dec 16, 4:00:02 PM EST
Earnings Call Transcripts
This Quarter (Q4 '25)
No earnings call transcript available yet
Last Quarter (Q3 '25)
No earnings call transcript available
Key Stats
Market Cap
173.68MP/E (TTM)
-Basic EPS (TTM)
-0.22Dividend Yield
0%Recent Filings
8-K
Zevia posts investor update
Zevia PBC released its August 2025 investor presentation on August 25, 2025, under Regulation FD, posting it to its website for use in upcoming investor discussions starting August 26. The materials offer summary insights tied to SEC filings and public announcements, yet carry forward-looking statements with inherent risks. No specific financial details emerge here.
8-K
Zevia launches $20M stock offering
Zevia PBC entered an Equity Distribution Agreement on August 12, 2025, with Piper Sandler & Co. to sell up to $20 million in Class A common stock via at-the-market offerings. The company will pay a 3% commission and use net proceeds to buy Zevia LLC units, fund marketing, pursue acquisitions, and support working capital. No sales obligation exists; the deal bolsters flexibility amid growth pursuits. Termination remains straightforward for either party.
8-K
Zevia hits positive EBITDA
Zevia reported Q2 2025 net sales of $44.5 million, up 10.1% from last year, fueled by 14.3% volume growth from Walmart expansion and drug channel gains, yet offset by promotions. Gross margins climbed to 48.7%, driving positive adjusted EBITDA of $0.2 million—its first. Zevia holds $26.3 million in cash with no debt. Momentum builds, but tariffs loom.
10-Q
Q2 FY2025 results
Zevia posted solid Q2 momentum with net sales climbing 10.1% year-over-year to $44.5M, fueled by expanded distribution in mass and drug channels, while gross margin expanded to 48.7% from 41.9% thanks to the Productivity Initiative's cost efficiencies and lower inventory write-downs. Operating loss narrowed sharply to $1.0M from $7.1M, with diluted EPS improving to $(0.01) from $(0.10); YTD figures show sales up 4.2% to $82.5M and EPS at $(0.09) versus $(0.20), reconciling cleanly to 64.7M weighted shares. Cash sits at $26.3M with no debt on the $20M revolver, but free cash flow isn't disclosed in the 10-Q. The Productivity Initiative delivered $20M in expected annualized savings, reinvested into marketing. Tariffs on steel and aluminum pose ongoing cost risks.
8-K
Board change and meeting results
Zevia PBC's Board shrank to seven members on June 12, 2025, after director Rosemary Ripley stepped down, citing no disagreements with company operations. At the same day's annual meeting, shareholders elected Andrew Ruben, Padraic L. Spence, and Amy E. Taylor as Class I directors for three-year terms, with strong support exceeding 85% for each. They also ratified Deloitte & Touche LLP as auditors for 2025. Board continuity holds firm.
IPO
Website
Employees
Sector
Industry
ABEV
Ambev S.A.
2.55-0.04
CCEP
Coca-Cola Europacific Partners
92.11+0.17
CELH
Celsius Holdings, Inc.
43.15-0.65
COCO
The Vita Coco Company, Inc.
52.21-1.82
FIZZ
National Beverage Corp.
33.25-0.66
JSDA
Jones Soda Co.
0.34-0.01
KO
Coca-Cola Company (The)
70.37-0.60
PEP
Pepsico, Inc.
150.37-0.85
PRMB
Primo Brands Corporation
16.47-0.15
SBEV
Splash Beverage Group, Inc. (NV
1.12-0.04